These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 826183)

  • 21. An analogue of thyrotropin releasing hormone with improved biological stability both in vitro and in vivo.
    Brewster D; Rance MJ
    Biochem Pharmacol; 1980 Oct; 29(19):2619-23. PubMed ID: 6775640
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of bacitracin as an inhibitor of the degradation of thyrotropin releasing factor and luteinizing hormone releasing factor.
    McKelvy JF; LeBlanc P; Laudes C; Perrie S; Grimm-Jorgensen Y; Kordon C
    Biochem Biophys Res Commun; 1976 Nov; 73(2):507-15. PubMed ID: 826254
    [No Abstract]   [Full Text] [Related]  

  • 23. [Synthesis and spectroscopic investigation of Namide-ethylthyroliberin (author's transl)].
    Kalbacher H; König WA; Voelter W
    Hoppe Seylers Z Physiol Chem; 1975 Nov; 356(11):1827-9. PubMed ID: 812793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of cold-stimulated thyrotropin secretion by antiserum to thyrotropin-releasing hormone.
    Szabo M; Frohman LA
    Endocrinology; 1977 Oct; 101(4):1023-33. PubMed ID: 409598
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative assessment of the specific activity of several thyrotropin-releasing-hormone analogs].
    Morozova LG; Smirnova AP; Shvachkin IP; Fedotov VP
    Biull Eksp Biol Med; 1976 Jun; 81(6):745-7. PubMed ID: 821571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational study of thyrotrophin-releasing hormone. I. Aspects of importance in the design of novel TRH analogues.
    Ward DJ; Griffiths EC; Robson B
    Int J Pept Protein Res; 1986 May; 27(5):461-71. PubMed ID: 3089959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological activity of TRH thionalogue and its diastereoisomers.
    Alexandrová M; Strbák V; Herman ZS; Stachura Z; Kruszyński M
    Endocrinol Exp; 1987 Mar; 21(1):43-9. PubMed ID: 3106009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of passive immunization with an antiserum to thyrotropin (TSH)-releasing hormone on plasma TSH levels in thyroidectomized rats.
    Szabo M; Kovathana N; Gordon K; Frohman LA
    Endocrinology; 1978 Mar; 102(3):799-805. PubMed ID: 105872
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence of thyrotropin-releasing hormone activity in autopsy pancreata from newborns.
    Koivusalo F
    J Clin Endocrinol Metab; 1981 Oct; 53(4):734-6. PubMed ID: 6793606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolites of thyrotropin releasing hormone inhibit angiotensin converting enzyme in vitro.
    MacGregor JS; Resnick LM; Laragh JH
    Biochem Biophys Res Commun; 1982 Nov; 109(2):556-61. PubMed ID: 6295402
    [No Abstract]   [Full Text] [Related]  

  • 31. Beneficial effect of the TRH analog CG-3703 on outcome and survival following traumatic brain injury in rats.
    McIntosh TK; Vink R; Faden AI
    Prog Clin Biol Res; 1988; 264():415-20. PubMed ID: 3132723
    [No Abstract]   [Full Text] [Related]  

  • 32. [Synthesis of thyrotropin releasing hormone (TRH) and its analogs].
    Bańkowski K; Drabarek S
    Acta Pol Pharm; 1976; 33(1):81-6. PubMed ID: 817571
    [No Abstract]   [Full Text] [Related]  

  • 33. Characteristics of the pituitary binding sites for thyrotropin releasing factor.
    Grant G; Vale W; Guillemin R
    Endocrinology; 1973 Jun; 92(6):1629-33. PubMed ID: 4196427
    [No Abstract]   [Full Text] [Related]  

  • 34. Benzodiazepine interactions with central thyroid-releasing hormone binding sites: characterization and physiological significance.
    Rinehart RK; Barbaz B; Iyengar S; Ambrose F; Steel DJ; Neale RF; Petrack B; Bittiger H; Wood PL; Williams M
    J Pharmacol Exp Ther; 1986 Jul; 238(1):178-85. PubMed ID: 3014114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth, serum growth hormone, thyroxine, prolactin and insulin in calves after thyrotropin releasing hormone or 3-methyl-thyrotropin releasing hormone.
    McGuffey RK; Thomas JW; Convey EM
    J Anim Sci; 1977 Mar; 44(3):422-30. PubMed ID: 403169
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro biochemical characterization and autoradiographic distribution of 3H-thyrotropin-releasing hormone binding sites in rat brain sections.
    Rostène WH; Morgat JL; Dussaillant M; Rainbow TC; Sarrieau A; Vial M; Rosselin G
    Neuroendocrinology; 1984 Jul; 39(1):81-6. PubMed ID: 6087185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological activities of thionated thyrotropin-releasing hormone analogs.
    Lankiewicz L; Bowers CY; Reynolds GA; Labroo V; Cohen LA; Vonhof S; Sirén AL; Spatola AF
    Biochem Biophys Res Commun; 1992 Apr; 184(1):359-66. PubMed ID: 1314591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and conformations of hypothalamic hormone releasing factors: two QRF-analogues containing backbone N-methyl groups.
    Donzel B; Goodman M; Rivier J; Ling N; Vale W
    Nature; 1975 Aug; 256(5520):750-1. PubMed ID: 807858
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunological blockade of endogenous thyrotropin-releasing hormone impairs recovery from hyperglycemia in mice.
    Amir S; Jackson IM
    Brain Res; 1988 Oct; 462(1):160-2. PubMed ID: 3141004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 13C nuclear magnetic resonance studies of the conformation of the X-pro bond in the oligopeptide hormones, thyrotropin-releasing hormone, luteinizing hormone-releasing factor, angiotensin and melanocyte-stimulating hormone release-inhibiting factor.
    Deslauriers R; Walter R; Smith IC
    Biochem Biophys Res Commun; 1973 Jul; 53(1):244-50. PubMed ID: 4354931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.